4D Molecular Therapeutics grants 35,200 RSUs to five new hires under inducement award plan
FDMT•RSU grants to five new hires
4D Molecular Therapeutics granted 35,200 restricted stock units to five new non-executive employees on Aug. 11, 2026.
The awards were issued under the company’s 2025 Employment Inducement Award Plan, as amended.
